Cytochrome P450 3A: ontogeny and drug disposition SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 37, 485-505, 1999 | 707 | 1999 |
Glucuronidation in humans: pharmacogenetic and developmental aspects SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 36, 439-452, 1999 | 482 | 1999 |
Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial I Ceelie, SN De Wildt, M Van Dijk, MMJ van den Berg, GE Van Den Bosch, ... Jama 309 (2), 149-154, 2013 | 258 | 2013 |
Why has model‐informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future AS Darwich, K Ogungbenro, AA Vinks, JR Powell, JL Reny, N Marsousi, ... Clinical Pharmacology & Therapeutics 101 (5), 646-656, 2017 | 208 | 2017 |
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review C Stillhart, K Vučićević, P Augustijns, AW Basit, H Batchelor, TR Flanagan, ... European Journal of Pharmaceutical Sciences 147, 105280, 2020 | 185 | 2020 |
Optimal sedation in pediatric intensive care patients: a systematic review NJ Vet, E Ista, SN de Wildt, M van Dijk, D Tibboel, M de Hoog Intensive care medicine 39, 1524-1534, 2013 | 185 | 2013 |
A systematic review of the therapeutic effects of Reiki S VanderVaart, VMGJ Gijsen, SN de Wildt, G Koren the Journal of alternative and complementary medicine 15 (11), 1157-1169, 2009 | 181 | 2009 |
Human ontogeny of drug transporters: review and recommendations of the pediatric transporter working group KLR Brouwer, LM Aleksunes, B Brandys, GP Giacoia, G Knipp, ... Clinical Pharmacology & Therapeutics 98 (3), 266-287, 2015 | 178 | 2015 |
Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters MG Mooij, UI Schwarz, BAE De Koning, JS Leeder, R Gaedigk, ... Drug Metabolism and Disposition 42 (8), 1268-1274, 2014 | 157 | 2014 |
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients SN De Wildt, M De Hoog, AA Vinks, E Van Der Giesen, JN Van Den Anker Critical care medicine 31 (7), 1952-1958, 2003 | 151 | 2003 |
Acute kidney injury is a frequent complication in critically ill neonates receiving extracorporeal membrane oxygenation: a 14-year cohort study AJM Zwiers, SN De Wildt, WCJ Hop, EM Dorresteijn, SJ Gischler, ... Critical care 17, 1-10, 2013 | 147 | 2013 |
The status of paediatric medicines initiatives around the world—what has happened and what has not? K Hoppu, G Anabwani, F Garcia-Bournissen, M Gazarian, GL Kearns, ... European journal of clinical pharmacology 68, 1-10, 2012 | 126 | 2012 |
Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for … L Schrier, A Hadjipanayis, T Stiris, RI Ross-Russell, A Valiulis, MA Turner, ... European journal of pediatrics 179, 839-847, 2020 | 119 | 2020 |
Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients V Gijsen, S Mital, RH Van Schaik, OP Soldin, SJ Soldin, ... The Journal of heart and lung transplantation 30 (12), 1352-1359, 2011 | 117 | 2011 |
The COMFORT behaviour scale detects clinically meaningful effects of analgesic and sedative treatment AA Boerlage, E Ista, HJ Duivenvoorden, SN De Wildt, D Tibboel, ... European Journal of Pain 19 (4), 473-479, 2015 | 112 | 2015 |
Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations I Ince, CAJ Knibbe, M Danhof, SN de Wildt Clinical pharmacokinetics 52, 333-345, 2013 | 105 | 2013 |
Pharmacokinetics and metabolism of oral midazolam in preterm infants SN De Wildt, GL Kearns, WCJ Hop, DJ Murry, SM Abdel‐Rahman, ... British journal of clinical pharmacology 53 (4), 390-392, 2002 | 105 | 2002 |
Disease‐associated changes in drug transporters may impact the pharmacokinetics and/or toxicity of drugs: a white paper from the International Transporter Consortium R Evers, M Piquette‐Miller, JW Polli, FGM Russel, JA Sprowl, K Tohyama, ... Clinical Pharmacology & Therapeutics 104 (5), 900-915, 2018 | 104 | 2018 |
Inflammation and organ failure severely affect midazolam clearance in critically ill children NJ Vet, JM Brussee, M de Hoog, MG Mooij, CWM Verlaat, IS Jerchel, ... American journal of respiratory and critical care medicine 194 (1), 58-66, 2016 | 104 | 2016 |
Pharmacokinetics and metabolism of intravenous midazolam in preterm infants SN De Wildt, GL Kearns, WCJ Hop, DJ Murry, SM Abdel‐Rahman, ... Clinical Pharmacology & Therapeutics 70 (6), 525-531, 2001 | 104 | 2001 |